Read + Share
Levallet G, Dubois F, Elie N, Creveuil C, et al. VEGFR2 and CD34 expression associated with longer survival in patients with
pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial. Lung Cancer 2023;182:107287.
PMID: 37393757
|
 |
|
Levallet G, Dubois F, Elie N, Creveuil C, et al. VEGFR2 and CD34 expression associated with longer survival in patients with
pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial. Lung Cancer 2023;182:107287.
PMID: 37393757
|
|
|
|